Current Status of Epigenetics and Anticancer Drug Discovery
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
16
Page:
699-712
Author(s):
Ping Jin and Xiaofei Chen
Metal Containing Cytostatics and Their Interaction with Cellular Thiol Compounds Causing Chemoresistance
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
16
Page:
686-698
Author(s):
Jan Hrabeta, Vojtech Adam, Tomas Eckschlager, Eva Frei, Marie Stiborova and Rene Kizek
Targeting the Cancer Biomarker CD47: A Review on the Diverse Mechanisms of the CD47 Pathway in Cancer Treatment
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
16
Page:
658-667
Author(s):
Liang Zhang and He Huang
Synthesis of 9-O-3-(1-piperazinyl/morpholinyl/piperidinyl)pentyl-berberines as Potential Antioxidant and Cytotoxic Agents
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
16
Page:
713-721
Author(s):
Bhupendra M. Mistry, Rahul V. Patel, Young-Soo Keum and Doo Hwan Kim
Polymer-Drug Nanoconjugate – An Innovative Nanomedicine: Challenges and Recent Advancements in Rational Formulation Design for Effective Delivery of Poorly Soluble Drugs
Journal:
Pharmaceutical Nanotechnology
Volume:
4
Page:
38-79
Author(s):
Amos O. Abioye, George Tangyie Chi, Adeola T. Kola-Mustapha, Ketan Ruparelia, Ken Beresford and Randolph Arroo
ISCHEMIRs: Finding a Way Through the Obstructed Cerebral Arteries
Journal:
Current Drug Targets
Volume:
17
Page:
800-810
Author(s):
Sreekala S. Nampoothiri, Hari Vinayak Menon, Debashish Das and Rajanikant Golgodu Krishnamurthy
Emerging Immunotargets in Bladder Cancer
Journal:
Current Drug Targets
Volume:
17
Page:
757-770
Author(s):
Francesco Massari, Chiara Ciccarese, Nuno Vau, Matteo Santoni, Rodolfo Montironi, Liang Cheng, Rita C. Marques, Marina Scarpelli, Jorge Fonseca, Marc R Matrana, Moch Holger, Stefano Cascinu, Giampaolo Tortora and Antonio Lopez-Beltran
The High Mobility Group A1 (HMGA1) Transcriptome in Cancer and Development
Journal:
Current Molecular Medicine
Volume:
16
Page:
353-393
Author(s):
T.F. Sumter, L. Xian, T. Huso, M. Koo, Y.-T. Chang, T.N. Almasri, L. Chia, C. Inglis, D. Reid and L.M.S. Resar
Targeted Inhibition of Rictor/mTORC2 in Cancer Treatment: A New Era after Rapamycin
Journal:
Current Cancer Drug Targets
Volume:
16
Page:
288-304
Author(s):
Zhipeng Zou, Juan Chen, Jun Yang and Xiaochun Bai
A New Therapeutic Era in GCB and ABC Diffuse Large B-cell Lymphom a Molecular Subtypes: A Cell of Origin-Driven Review
Journal:
Current Cancer Drug Targets
Volume:
16
Page:
305-322
Author(s):
Jose D. Sandoval-Sus, Julio Chavez and Samir Dalia